CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Stemline Therapeutics Inc  (STML)
Other Ticker:  
 

Stemline Therapeutics Inc's Working Capital Ratio

STML's quarterly Working Capital Ratio and Current Assets, Current Liabilities growth




STML Working Capital Ratio (Sep 30 2018)
III. Quarter
(Mar 31 2018)
I. Quarter
(Dec 31 2017)
IV. Quarter
(Sep 30 2017)
III. Quarter
(Jun 30 2017)
II. Quarter
Y / Y Current Liabilities Change 24.77 % 48.32 % 93.48 % 58.69 % 55.44 %
Y / Y Current Assets Change 24.74 % 11.57 % 10.64 % 29.59 % 9.65 %
Working Capital Ratio MRQ 4.65 5.14 2.63 4.57 4.65
Overall Ranking # 829 # # 868 # 1697 # 985
Seq. Current Liabilities Change -11.49 % -1.28 % 37.15 % 4.11 % 5.21 %
Seq. Current Assets Change -19.95 % 92.77 % -21.07 % 2.43 % -28.41 %



Working Capital Ratio third quarter 2018 Comment
Despite sequential decrease in Current Liabilities, Working Capital Ratio detoriated to 4.65 below company average Working Capital Ratio.

Within Major Pharmaceutical Preparations industry 120 other companies have achieved higher Working Capital Ratio than Stemline Therapeutics Inc in third quarter 2018. While Working Capital Ratio total ranking has deteriorated compare to previous quarter from to 829.

Explain Working Capital Ratio
Where is STML most successful ?
Working Capital Ratio STML on the trailing twelve month basis
Working Capital Ratio third quarter 2018 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 121
Healthcare Sector # 275
Overall Market # 829


Working Capital Ratio Statistics
High Average Low
31.09 9.37 2.63
(Sep 30 2013)   (Dec 31 2017)




Financial Statements
Stemline Therapeutics Inc's Current Liabilities $ 17 Millions Visit STML's Balance sheet
Stemline Therapeutics Inc's Current Assets $ 81 Millions Visit STML's Balance sheet
Source of STML's Sales Visit STML's Sales by Geography




Companies with similar Working Capital Ratio in the quarter endingSep 30 2018, within Major Pharmaceutical Preparations Industry Working Capital RatioSep 30 2018 MRQ Current AssetsSep 30 2018 MRQ Current Liabilities
Ovascience, Inc.  12.62 $ 48.986  Millions$ 3.881  Millions
Reata Pharmaceuticals Inc  12.05 $ 379.818  Millions$ 31.532  Millions
Zafgen, Inc.  11.78 $ 131.469  Millions$ 11.164  Millions
Beigene, Ltd.  11.57 $ 2,180.195  Millions$ 188.424  Millions
Arbutus Biopharma Corp  11.37 $ 144.025  Millions$ 12.668  Millions
Alnylam Pharmaceuticals, Inc.  11.37 $ 1,342.120  Millions$ 118.059  Millions
Mirati Therapeutics, Inc.  11.22 $ 246.098  Millions$ 21.941  Millions
Abeona Therapeutics Inc.  11.09 $ 114.551  Millions$ 10.331  Millions
Kindred Biosciences, Inc.  10.82 $ 95.852  Millions$ 8.858  Millions
Catabasis Pharmaceuticals Inc  10.80 $ 44.541  Millions$ 4.125  Millions
Spring Bank Pharmaceuticals, Inc.  10.66 $ 54.534  Millions$ 5.114  Millions
Cytokinetics Inc  10.57 $ 227.269  Millions$ 21.492  Millions
Bellicum Pharmaceuticals, Inc.  10.38 $ 115.539  Millions$ 11.128  Millions
Ra Pharmaceuticals, Inc.  10.29 $ 83.561  Millions$ 8.117  Millions
Flex Pharma, Inc.  10.26 $ 13.684  Millions$ 1.333  Millions
Savara Inc.  10.23 $ 114.745  Millions$ 11.220  Millions
Blueprint Medicines Corp  10.05 $ 565.657  Millions$ 56.279  Millions
Oragenics Inc  9.94 $ 15.472  Millions$ 1.557  Millions
Arqule Inc  9.60 $ 107.358  Millions$ 11.188  Millions
Amicus Therapeutics Inc  9.52 $ 601.034  Millions$ 63.130  Millions
Progenics Pharmaceuticals Inc  9.51 $ 156.909  Millions$ 16.495  Millions
Aeglea Biotherapeutics, Inc.  9.37 $ 70.382  Millions$ 7.515  Millions
Aduro Biotech, Inc.  9.32 $ 287.763  Millions$ 30.885  Millions
Xbiotech Inc.  9.26 $ 21.306  Millions$ 2.300  Millions
Alpine Immune Sciences, Inc.  9.19 $ 63.080  Millions$ 6.867  Millions
Fibrocell Science, Inc.  9.06 $ 16.405  Millions$ 1.811  Millions
Adamas Pharmaceuticals Inc  8.95 $ 226.304  Millions$ 25.298  Millions
Flexion Therapeutics Inc  8.88 $ 321.410  Millions$ 36.212  Millions
Sarepta Therapeutics, Inc.  8.85 $ 1,012.077  Millions$ 114.393  Millions
Dermira, Inc.  8.83 $ 393.184  Millions$ 44.549  Millions


     
       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

OGEN's Profile

Stock Price

OGEN's Financials

Business Description

Fundamentals

Charts & Quotes

OGEN's News

Suppliers

OGEN's Competitors

Customers & Markets

Economic Indicators

OGEN's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2018 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071